Evidence map›Paper›PMID 39580037›Full record

ReviewSeminars in ultrasound, CT, and MR2025

Interpreting Prostate Multiparametric MRI: Beyond Adenocarcinoma - Anatomical Variations, Mimickers, and Post-Intervention Changes.

Enis C Yilmaz, Omer Tarik Esengur, David G Gelikman, Baris Turkbey

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Seminars in ultrasound, CT, and MR, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Enis C YilmazMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Omer Tarik EsengurMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
David G GelikmanMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.
Baris TurkbeyMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address: turkbeyi@mail.nih.gov.

Funding

Imaging, image guided biopsy and treatment of prostate cancerZIABC012062 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TÜRKBEY, BARIS · 2021 to 2025
$1.3M
Intramural NIH HHS ZIA BC012062
6 · The paper itself

Abstract

Prostate magnetic resonance imaging (MRI) is an essential tool in the diagnostic pathway for prostate cancer. However, its accuracy can be confounded by a spectrum of noncancerous entities with similar radiological features, posing a challenge for definitive diagnosis. This review synthesizes current knowledge on the MRI phenotypes of both common and rare benign prostate conditions that may be mistaken for malignancy. The narrative encompasses anatomical variants, other neoplastic processes, inflammatory conditions, and alterations secondary to medical interventions. Furthermore, this review underscores the critical role of MRI quality in diagnostic accuracy and explores the emerging contributions of artificial intelligence in enhancing image interpretation.

Indexed as

AdenocarcinomaImage Interpretation, Computer-AssistedMultiparametric Magnetic Resonance ImagingProstatic NeoplasmsDiagnosis, DifferentialHumansMaleProstate

Identifiers

PMID39580037
PMCPMC11741936

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.